Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Caribou Biosciences (CRBU) Return on Equity (2020 - 2025)

Historic Return on Equity for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to 1.03%.

  • Caribou Biosciences' Return on Equity fell 4700.0% to 1.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.03%, marking a year-over-year decrease of 4700.0%. This contributed to the annual value of 0.48% for FY2024, which is 1700.0% down from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Return on Equity is 1.03%, which was down 4700.0% from 0.87% recorded in Q2 2025.
  • Caribou Biosciences' Return on Equity's 5-year high stood at 1.27% during Q1 2021, with a 5-year trough of 1.03% in Q3 2025.
  • Over the past 5 years, Caribou Biosciences' median Return on Equity value was 0.35% (recorded in 2021), while the average stood at 0.27%.
  • As far as peak fluctuations go, Caribou Biosciences' Return on Equity plummeted by -21500bps in 2021, and later surged by 700bps in 2022.
  • Quarter analysis of 5 years shows Caribou Biosciences' Return on Equity stood at 0.17% in 2021, then tumbled by -102bps to 0.34% in 2022, then increased by 11bps to 0.3% in 2023, then crashed by -106bps to 0.62% in 2024, then crashed by -65bps to 1.03% in 2025.
  • Its Return on Equity was 1.03% in Q3 2025, compared to 0.87% in Q2 2025 and 0.7% in Q1 2025.